发明名称 MICRORNA MEDIATED ONCOLYTIC TARGETING
摘要 <p>The invention provides methods for preferentially killing target cells in a host by infecting the cells with one or more strains of a lytic virus that has been engineered to be susceptible to microRNA mediated translational repression. Methods of the invention thereby exploit differential microRNA expression in target and non - target cells of the host. For example, altered expression of microRNAs in cancer cells can be exploited to alter expression of a viral gene in cancer cells, compared t o non0cancerous cells, to achieve tumour specific replication of an engineered virus, such as a vesicular stomatitis virus (VSV). In a selected embodiment, incorporati on of let-7a microRNA complementary sequences within the VSV genome attenuates vir al replication and associated toxicity in normal cells, but permits growth in cancer cells.</p>
申请公布号 CA2625811(A1) 申请公布日期 2009.09.14
申请号 CA20082625811 申请日期 2008.03.14
申请人 OTTAWA HEALTH RESEARCH INSTITUTE 发明人 EDGE, ROBERT;BELL, JOHN C.
分类号 C12N7/01;A61K35/76;A61K48/00;A61P35/00;C12N15/11;C12N15/86 主分类号 C12N7/01
代理机构 代理人
主权项
地址